Real-World test for anthrax drug seeks to save lives
NCT ID NCT07478471
Summary
This study aims to learn how well the drug raxibacumab works and how safe it is for people with a confirmed, serious anthrax infection. It will observe up to 10 patients in the US who receive the drug from the national stockpile as part of their standard medical care. Researchers will collect information on survival, side effects, and how the drug behaves in the body to better guide future treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS, BACTERIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.